In this free webinar, learn about a unique platform for serological testing that streamlines validated analytical assays with faster, more reliable results. Attendees will be introduced to the VaxArray Platform and its key advantages over traditional approaches, including sample processing in as little as 30 minutes with real-world data collection. The featured speaker will also discuss the benefits of developing and testing custom and pre-validated kits with specific project examples.
TORONTO, June 26, 2024 /PRNewswire-PRWeb/ -- Serological testing plays a pivotal role in understanding pre-existing immunity, infection and immunogenicity. However, conventional characterization assays often pose challenges in terms of complexity, time consumption and resource requirements, particularly when assessing antibody titers against multiple targets.
InDevR's VaxArray® Platform addresses these logistical hurdles by simplifying and streamlining analytical development through its innovative, multiplexed microarray-based technology. This technology enables the generation of multiple results from a single test for high-value applicability to multivalent vaccines.
The VaxArray Platform comprises a versatile range of applications in serology and vaccine analytics, encompassing serum antibody quantification, identity testing, antigen quantification, characterization of nucleic acid vaccine constructs and assessment of cell-based potency assays for mRNA vaccines. InDevR's off-the-shelf, multiplexed kits, alongside user-friendly instrumentation and data analysis tools, facilitate rapid sample processing with a typical turnaround time of less than 90 minutes.
In this webinar, the expert speaker will showcase the utility of the VaxArray Platform in serological testing, emphasizing its distinctive advantages in this field compared to traditional approaches. They will also focus on off-the-shelf kits tailored for COVID serological testing and serological applications for pneumococcal conjugate vaccines, in addition to a review of corresponding data. Additionally, the speaker will discuss about custom kit development for serological testing, including specific examples of custom serology projects.
Register for this webinar today to gain insights into the transformative capabilities of an innovative, multiplexed microarray-based technology for serological testing and vaccine analytics.
Join April Ruka, PhD, Application Scientist, , for the on Tuesday, July 16, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit .
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit
For information about hosting a webinar visit
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected],
SOURCE Xtalks
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN47999&Transmission_Id=202406260830PR_NEWS_USPR_____UN47999&DateId=20240626)
Share this article